Alan T. Remaley

31.3k total citations · 8 hit papers
384 papers, 22.3k citations indexed

About

Alan T. Remaley is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Alan T. Remaley has authored 384 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Surgery, 127 papers in Endocrinology, Diabetes and Metabolism and 123 papers in Molecular Biology. Recurrent topics in Alan T. Remaley's work include Lipoproteins and Cardiovascular Health (113 papers), Cholesterol and Lipid Metabolism (110 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (98 papers). Alan T. Remaley is often cited by papers focused on Lipoproteins and Cardiovascular Health (113 papers), Cholesterol and Lipid Metabolism (110 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (98 papers). Alan T. Remaley collaborates with scholars based in United States, Australia and Japan. Alan T. Remaley's co-authors include Kasey C. Vickers, Robert D. Shamburek, Bassem M. Shoucri, Brian T. Palmisano, Marcelo Amar, H. Bryan Brewer, Silvia Santamarina-Fojo, John A. Stonik, Maureen Sampson and Edward B. Neufeld and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alan T. Remaley

378 papers receiving 21.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

2011 2.2k citations Kasey C. Vickers, Robert D. Shamburek et al. profile →
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

2001 987 citations Alan T. Remaley et al. profile →
Cholesterol Efflux and Atheroprotection

2012 740 citations Robert S. Rosenson, H. Bryan Brewer et al. Circulation profile →
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

2011 391 citations Robert S. Rosenson, H. Bryan Brewer et al. profile →
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

2018 329 citations Alan T. Remaley et al. profile →
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

2020 312 citations Maureen Sampson, Amar A Sethi et al. profile →
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research

2021 198 citations Anand Rohatgi, Marit Westerterp et al. Circulation profile →
High-density lipoprotein revisited: biological functions and clinical relevance

2022 185 citations Arnold von Eckardstein, Alan T. Remaley et al. profile →

Peers

Countries citing papers authored by Alan T. Remaley

Since Specialization

Citations

This map shows the geographic impact of Alan T. Remaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Remaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Remaley more than expected).

Fields of papers citing papers by Alan T. Remaley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan T. Remaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Remaley. The network helps show where Alan T. Remaley may publish in the future.

Co-authorship network of co-authors of Alan T. Remaley

This figure shows the co-authorship network connecting the top 25 collaborators of Alan T. Remaley. A scholar is included among the top collaborators of Alan T. Remaley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan T. Remaley. Alan T. Remaley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD 2025 ·Molecular Neurodegeneration ·Shaowei Wang, Boyang Li, Jie Li, (unknown), (unknown), Yi Sun, Qian Lü, Julia TCW, Helena C. Chui, (unknown), Isaac Asante, Stan G. Louie, David A. Bennett, Zoe Arvanitakis, Alan T. Remaley, Bilal E. Kerman, Hussein N. Yassine	9
2	Endogenous Ketone Bodies Are Associated with Metabolic Vulnerability and Disability in Multiple Sclerosis 2025 ·Nutrients ·(unknown), Irina Shalaurova, Anna Wolska, Richard W. Browne, Bianca Weinstock‐Guttman, Robert Zivadinov, Alan T. Remaley, James D. Otvos, Murali Ramanathan	2
3	Untargeted lipidomics reveals novel HDL metabotypes and lipid-clinical correlates 2024 ·Journal of Lipid Research ·Peer W. F. Karmaus, Scott M. Gordon, Marcus Y. Chen, Alison A. Motsinger‐Reif, Rodney W. Snyder, Timothy R. Fennell, Suramya Waidyanatha, Reshan A. Fernando, Alan T. Remaley, Michael B. Fessler	2
4	A High-Throughput NMR Method for Lipoprotein-X Quantification 2024 ·Molecules ·Erwin Garcia, Irina Shalaurova, Steven P. Matyus, Lita A. Freeman, Edward B. Neufeld, Maureen Sampson, (unknown), Anna Wolska, Alan T. Remaley, James D. Otvos, Margery A. Connelly	2
5	Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor 2024 ·Nature ·(unknown), Altaira D. Dearborn, Giorgio Maria Paolo Graziano, (unknown), (unknown), Ashish Kumar, Ronald J. Holewinski, Edward B. Neufeld, Francis J. O’Reilly, Alan T. Remaley, Joseph Marcotrigiano	19
6	Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease 2023 ·JCI Insight ·Alexander V. Sorokin, (unknown), Angel Aponte, (unknown), Jingrong Tang, Nidhi Patel, Irina N. Baranova, Haiou Li, Philip M. Parel, Vicky Chen, (unknown), Emily L. Ongstad, Anna Collén, Martin P. Playford, Thomas L. Eggerman, Marcus Y. Chen, Kazuhiko Kotani, Alexander V. Bocharov, Alan T. Remaley	6
7	Colchicine effects on the gut microbiome in adults with metabolic syndrome 2023 ·Bioscience of Microbiota Food and Health ·(unknown), (unknown), (unknown), Poorani Subramanian, Shreni Mistry, Anna Wolska, Alan T. Remaley, Jack A. Yanovski, Andrew P. Demidowich	3
8	Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome 2022 ·Obesity ·J Levine, (unknown), Tushar Patel, Sheila M. Brady, (unknown), (unknown), Jung Min Han, Vipul Periwal, Anna Wolska, Alan T. Remaley, Pradeep K. Dagur, Angélique Biancotto, Ashley L. Babyak, Giovanna Fantoni, Jack A. Yanovski, Andrew P. Demidowich	10
9	Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations 2022 ·Biomedicines ·Maureen Sampson, Anna Wolska, (unknown), (unknown), James D. Otvos, Jeff W. Meeusen, Leslie J. Donato, Allan S. Jaffe, Alan T. Remaley	15
10	A new phenotypic classification system for dyslipidemias based on the standard lipid panel 2021 ·Lipids in Health and Disease ·Maureen Sampson, Rami A. Ballout, Daniel Soffer, Anna Wolska, (unknown), Jeff W. Meeusen, Leslie J. Donato, (unknown), James D. Otvos, Eliot A. Brinton, Robert S. Rosenson, Peter W.F. Wilson, Marcelo Amar, Robert D. Shamburek, Sotirios K. Karathanasis, Alan T. Remaley	11
11	Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects: A Lipidomic Analysis of the VOHF Study 2021 ·Molecular Nutrition & Food Research ·Sara Fernández‐Castillejo, Anna Pedret, Úrsula Catalán, Rosa M. Valls, Marta Farràs, Laura Rubió, Olga Castañer, Alba Macià, Montserrat Fitó, María‐José Motilva, María‐Isabel Covas, Martin Giera, Alan T. Remaley, Rosa Solà	15
12	HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research breakdown → 2021 ·Circulation ·Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, Alan T. Remaley, Kerry‐Anne Rye	198
13	Apolipoprotein A‐I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high‐density lipoproteins assembled by ABCA1 and LCAT 2020 ·FEBS Letters ·Maki Tsujita, Boris Vaisman, Chengyu Liu, Kasey C. Vickers, Keiichiro Okuhira, Sten Braesch‐Andersen, Alan T. Remaley	15
14	SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation 2020 ·PLoS ONE ·Tatyana G. Vishnyakova, Alexander V. Bocharov, Irina N. Baranova, Roger Kurlander, Steven K. Drake, Zhigang Chen, Marcelo Amar, Denis Sviridov, Boris Vaisman, Eugenia Poliakov, Alan T. Remaley, Thomas L. Eggerman, Amy P. Patterson	5
15	Effect of niacin monotherapy on high density lipoprotein composition and function 2020 ·Lipids in Health and Disease ·Scott M. Gordon, Marcelo Amar, (unknown), Michael Stagliano, (unknown), Martin P. Playford, Nehal N. Mehta, Tomáš Vaisar, Alan T. Remaley	17
16	Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol 2018 ·eLife ·Kelly A. Manthei, Shyh‐Ming Yang, Bolormaa Baljinnyam, Louise Chang, Alisa Glukhova, Wenmin Yuan, Lita A. Freeman, David J. Maloney, Anna Schwendeman, Alan T. Remaley, Ajit Jadhav, J.J.G. Tesmer	31
17	Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression 2016 ·Translational Psychiatry ·M. Pavlatou, Alan T. Remaley, P W Gold	36
18	Apolipoproteins and Apolipoprotein Mimetic Peptides Modulate Phagocyte Trafficking through Chemotactic Activity 2012 ·Journal of Biological Chemistry ·Jennifer H. Madenspacher, Kathleen M. Azzam, Wanghua Gong, Kymberly M. Gowdy, Michael P. Vitek, Daniel T. Laskowitz, Alan T. Remaley, Ji Ming Wang, Michael B. Fessler	32
19	High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen–Independent Cancer Cells by an ABCA1-Dependent Mechanism 2010 ·Molecular Cancer Research ·Yoshitaka Sekine, Steve J. Demosky, John A. Stonik, Yosuke Furuya, Hidekazu Koike, Kazuhiro Suzuki, Alan T. Remaley	63
20	Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides 2008 ·Journal of Biological Chemistry ·Amar A Sethi, John A. Stonik, Thomas Fairwell, Steve J. Demosky, Marcelo Amar, Edward B. Neufeld, H. Bryan Brewer, W. Sean Davidson, Wilissa D’Souza, Dmitri Sviridov, Alan T. Remaley	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact